ES2175123T3 - Procedimiento que sirve para determinar la concentracion de oxigeno enuna muestra. - Google Patents

Procedimiento que sirve para determinar la concentracion de oxigeno enuna muestra.

Info

Publication number
ES2175123T3
ES2175123T3 ES96929434T ES96929434T ES2175123T3 ES 2175123 T3 ES2175123 T3 ES 2175123T3 ES 96929434 T ES96929434 T ES 96929434T ES 96929434 T ES96929434 T ES 96929434T ES 2175123 T3 ES2175123 T3 ES 2175123T3
Authority
ES
Spain
Prior art keywords
sample
oxygen
concentration
serves
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96929434T
Other languages
English (en)
Inventor
Jan Henrik Ardenkjaer-Larsen
Ib Leunbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9518442.0A external-priority patent/GB9518442D0/en
Priority claimed from GBGB9612931.7A external-priority patent/GB9612931D0/en
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Application granted granted Critical
Publication of ES2175123T3 publication Critical patent/ES2175123T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/20—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/62—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using double resonance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G01R33/281—Means for the use of in vitro contrast agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating And Analyzing Materials By Characteristic Methods (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

SE SUMINISTRA UN METODO PARA DETERMINAR LA CONCENTRACION DE OXIGENO EN UNA MUESTRA USANDO RESONANCIA DE FORMACION DE IMAGENES POR RESONANCIA MAGNETICA POTENCIADA POR SPIN DE ELECTRONES.
ES96929434T 1995-09-08 1996-09-06 Procedimiento que sirve para determinar la concentracion de oxigeno enuna muestra. Expired - Lifetime ES2175123T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9518442.0A GB9518442D0 (en) 1995-09-08 1995-09-08 Method
US08/546,146 US5765562A (en) 1995-09-08 1995-10-20 Method for determining oxygen concentration using magnetic resonance imaging
GBGB9612931.7A GB9612931D0 (en) 1996-06-20 1996-06-20 Method

Publications (1)

Publication Number Publication Date
ES2175123T3 true ES2175123T3 (es) 2002-11-16

Family

ID=27267898

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96929434T Expired - Lifetime ES2175123T3 (es) 1995-09-08 1996-09-06 Procedimiento que sirve para determinar la concentracion de oxigeno enuna muestra.

Country Status (13)

Country Link
EP (1) EP0871896B1 (es)
JP (1) JP2002502491A (es)
CN (1) CN1200179A (es)
AT (1) ATE212727T1 (es)
AU (1) AU717685B2 (es)
CA (1) CA2231405A1 (es)
CZ (1) CZ66998A3 (es)
DE (1) DE69618991T2 (es)
ES (1) ES2175123T3 (es)
NO (1) NO980965L (es)
NZ (1) NZ316583A (es)
PL (1) PL325428A1 (es)
WO (1) WO1997009633A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164293A1 (de) * 2001-12-28 2003-07-10 Wagner Alarm Sicherung Verfahren und Vorrichtung zum Messen des Sauerstoffgehaltes
CA2541385C (en) 2003-09-05 2013-11-19 The Ohio State University Research Foundation Nanoparticulate probe for in vivo monitoring of tissue oxygenation
US8066973B2 (en) 2003-09-05 2011-11-29 The Ohio State University Research Foundation Nanoparticulate probe for in vivo monitoring of tissue oxygenation
NZ552898A (en) 2004-07-30 2011-02-25 Ge Healthcare As Method of producing a composition, composition and its use
JP5475995B2 (ja) 2005-12-01 2014-04-16 ジーイー・ヘルスケア・アクスイェ・セルスカプ 動的核分極（ｄｎｐ）法
CN101970014A (zh) * 2007-07-26 2011-02-09 通用电气医疗集团英国有限公司 包含超极化的13c-乳酸盐的成像介质及其用途
EP2072061A1 (en) 2007-12-19 2009-06-24 GE Healthcare Limited Composition and method for generating a metabolic profile using 13C-MR detection
US8697034B2 (en) 2008-10-10 2014-04-15 The Board Of Regents Of The University Of Texas System Hyperpolarized 89-yttrium and methods relating thereto
US8968703B2 (en) 2009-09-10 2015-03-03 Ge Healthcare Limited 13C-MR detection using hyperpolarised 13C-fructose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909270D0 (en) * 1989-04-24 1989-06-07 Hafslund Nycomed Innovation Method
FR2664705B1 (fr) * 1990-07-10 1992-09-18 Commissariat Energie Atomique Procede de detection ou de dosage d'oxygene par spectrometrie rpe utilisant des phtalocyanines de lithium radicalaire et composition utilisable pour le dosage "in vivo".

Also Published As

Publication number Publication date
CA2231405A1 (en) 1997-03-13
ATE212727T1 (de) 2002-02-15
DE69618991T2 (de) 2002-10-31
CZ66998A3 (cs) 1998-07-15
EP0871896B1 (en) 2002-01-30
AU6884796A (en) 1997-03-27
PL325428A1 (en) 1998-07-20
AU717685B2 (en) 2000-03-30
WO1997009633A1 (en) 1997-03-13
EP0871896A1 (en) 1998-10-21
NO980965D0 (no) 1998-03-05
CN1200179A (zh) 1998-11-25
NZ316583A (en) 1999-08-30
JP2002502491A (ja) 2002-01-22
DE69618991D1 (de) 2002-03-14
NO980965L (no) 1998-04-28

Similar Documents

Publication Publication Date Title
FI973122A7 (fi) Menetelmä ja yhdisteitä analysoitavien aineiden detektoimiseksi magnet orelaksometrisesti ja niiden käyttö
TR199800610A3 (tr) Toplam nükleer manyetik rezonans porozite (gözeneklilik) ölçümü için yöntem ve alet.
NO984355D0 (no) FremgangsmÕte for mÕling av en analytts konsentrasjon
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
GEP20012591B (en) Device for Detection of Analytes
DE69635193D1 (de) System zur Messung des elektrischen Potentials durch eine Membrane
ES2047334T3 (es) Metodo de analisis optico.
ES2175123T3 (es) Procedimiento que sirve para determinar la concentracion de oxigeno enuna muestra.
ES2165596T3 (es) Metodo para cuantificar la uniformidad visual de objetos planos.
DE69732034D1 (de) Assay-verfahren
FI973561L (fi) Menetelmä ja yhdisteitä analysoitavien aineiden määrittämiseksi remanenssimittausten avulla ja mainittujen yhdisteiden käyttö
NO930705L (no) Fremgangsmaate for bestemmelse av en vannbehandlingspolymer i en vandig proeve
NZ306622A (en) Method for diagnosing a patient for chlamydia
IT1294642B1 (it) Metodo per la determinazione della concentrazione di un analita mediante l'utilizzo di un bioelemento e dispositivo operante secondo
DE59009773D1 (de) Verfahren zur Konzentrationsbestimmung mittels Atomabsorptions-Spektroskopie.
ATE100938T1 (de) Verfahren zur bestimmung der thyroxinbindekapazitaet und dazu geeignete standardloesung.
FI973993A0 (fi) Menetelmä ja laite ferromagneettisten kohteiden mittaamiseksi
DE69526056D1 (de) Immunologisches Testverfahren zur Quantifizierung von PEG-modifiziertem humanem Granulozyten-Kolonie-Stimulierender-Faktor
KR970702928A (ko) 크립토콕쿠스증에 대해 위험이 큰 면역약화된 환자의 동정 방법(Method to identify immunocompromised patients at high risk for cryptococcosis)
ES8407585A1 (es) Un procedimiento para identificar y, en su caso, para determinar cuantitativamente los origenes biosinteticos yno tecnosinteticos de sustancias organicas
ES2160783T3 (es) Metodos para detectar parvovirus humano.
DK0912765T3 (da) Bestemmelse af analyter under anvendelse af to markører
ATE249622T1 (de) Vorrichtung zur konzentrationsmessung von wasserstoffperoxid
FI961808L (fi) Menetelmä ja laite paramagneettisen kaasun analysoimiseksi
EP0942283A3 (en) Methods and apparatus for improved immunoassay